Recurrent Meningioma
9 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma (NCT04659811) | Nancy Ann Oberheim Bush, MD | 2021-03-25 |
| Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy (NCT04082520) | Mayo Clinic | 2020-04-14 |
| Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma (NCT02847559) | Northwestern University | 2016-08-01 |
| Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas (NCT02523014) | Alliance for Clinical Trials in Oncology | 2015-09-28 |
Track Recurrent Meningioma automatically
Every clearance here is in the API, with alerts when new ones post.